Overview

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

Status:
Completed

Trial end date:
2020-04-01

Target enrollment:

Participant gender:

Summary

Ratiotherapy alone is the current standard treatment for elderly esophageal or esophagogastric cancer in China. And Little is known about chemoradiotherapy (CRT) in elderly patients. This study aimed to assess the efficiency and safety of simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) with S1 based SIB-IMRT followed by adjuvant chemotherapy with S1 in in elderly (age ≥70 years) esophageal or esophagogastric cancer patients

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Chinese Academy of Medical Sciences

Collaborators:

Affiliated Hospital of Hebei University
Anyang Tumor Hospital
Fujian Cancer Hospital
Hebei Medical University Fourth Hospital
Sichuan Cancer Hospital and Research Institute
Tengzhou Central People's Hospital
The Affiliated Hospital of Inner Mongolia Medical University
The First Affiliated Hospital of Zhengzhou University
The First Affiliated Hospital with Nanjing Medical University
Tianjin Medical University Cancer Institute and Hospital